Herein, our study reveals the impact of COL11A1 gene product in the alteration of PTEN, PIK3CA, KRAS, and BRAF which might downregulate the RTK-RAS-PI3K signaling pathways to induce cancer development (Figure 7A). The gene discussed is BRAF; the disease is cancer.